Monitoring and Management of Cytomegalovirus Reactivations After Allogeneic Hematopoietic Stem Cell Transplantation in Children: Experience from a Single Pediatric Center
Background: CMV reactivation represents a frequent complication after HSCT. The aim of this study was to describe the incidence of CMV reactivation in a pediatric HSCT cohort and analyze the potential impact of recipient/donor-related or transplant-related factors on this complication. Furthermore,...
Saved in:
| Main Authors: | Giulia Ferrando, Francesca Bagnasco, Stefano Giardino, Filomena Pierri, Sara Pestarino, Eddi Di Marco, Maria Santaniello, Elio Castagnola, Maura Faraci |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/14/21/2461 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune reconstitution of human cytomegalovirus-specific T lymphocytes after allogeneic hematopoietic stem cell transplantation and their predictive role in reactivation
by: Yuanqi Zhao, et al.
Published: (2025-03-01) -
Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions
by: A. A. Dmitrova, et al.
Published: (2022-06-01) -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?
by: Fabian Herrera
Published: (2024-04-01) -
Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01) -
Trends in the treatment of cytomegalovirus infection in oncohematological patients
by: D. N. Balashov
Published: (2014-07-01)